title: Switching from rosiglitazone: thinking outside the class.
authors.affiliation: Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, 333 Cedar St, SHM IE-60, New Haven, CT 06520, USA. kasia.lipska@yale.edu
authors.forename: Kasia J
authors.initials: KJ
authors.lastname: Lipska
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Ross
mesh_terms: D001786:Blood Glucose / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000453:epidemiology; D003657:Decision Making; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use; D000077205:Pioglitazone; D012306:Risk; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone